Oscor, Inc.
Industry
- Medical Devices
- Implantable Devices
See more in Biomedtracker
Latest on Oscor, Inc.
Medtech Insight
• By Beth Allan and Reed Miller
Deals In March MyungMoon Bio To Sell ACell's Wound Matrix Products In South Korea ACell Inc. granted MyungMoon Bio Co. Ltd. exclusive rights to market and distribute its wound management matrix pr
In Vivo
Exhibit 1 Top Alliances In March 2014 (Potential Deal Value In $M) *Potential deal value is the sum of up-front fees plus pre-commercialization money. Strategic Transactions Exhibit 2 Top Mergers & Ac
In Vivo
IN VITRO DIAGNOSTICS Mergers & Acquisitions Roche Roche Molecular Diagnostics IQuum Inc. Roche paid $275mm up front for private molecular diagnostics company IQuum Inc. , which is also eligible